Developing therapeutics for endocrine tumors: an interview with Gary Hammer
Take a look at a recent two part interview published in our partnered journal the International Journal of Endocrine Oncology. In part one of the interview, Gary D Hammer discusses the current research underway in his laboratory at the University of Michigan (MI, USA) and how he plans to make strides in the development of novel therapeutics for rare adrenal neoplasia’s and cancers. In part two, Hammer further explains how the Endocrine Oncology Program at the University of Michigan Rogel Cancer Center was initiated and developed over the years, as well as the importance of global engagement and patient advocacy.
